Navigation Links
Charlie Rose Science Series Explores Heart Disease
Date:9/17/2007

Episode Nine of Science Series to Focus on Cardiovascular Disease, Prevention and Treatment Options, and Global Trends That Undermine Care

Improvements

NEW YORK, Sept. 17 /PRNewswire/ -- The upcoming episode of the "Charlie Rose Science Series" on PBS will focus on heart disease, one of the leading global killers, which claims almost 900,000 lives each year in the United States alone. Co-host Sir Paul Nurse, Nobel Laureate and President of Rockefeller University and a panel of leading experts in cardiology and heart disease will join Charlie Rose. Guest panelists will address prevalence rates among men and women, the biology and genetics of the disease, the most common risk factors and how to reduce them, medical, surgical and interventional therapies, and steps that individuals can take toward a heart-healthy life style.

The ninth episode in the 12-part Science Series, which is sponsored by Pfizer Inc, will begin airing on Wednesday, September 19, 2007 on more than 200 PBS stations across the country.

Heart disease is the leading cause of death for both men and women in the United States, killing an average of one in four. Worldwide, heart disease claimed the lives of nearly 17.5 million people in 2005, making it the greatest cause of mortality across the globe. According to the Centers for Disease Control, heart disease, which is an umbrella term that includes all aspects and types of coronary and cardiovascular problems, and all subsequent related problems, will cost an estimated $258 billion dollars in health care services, medications, and lost productivity.

"Heart disease is a crucial concern worldwide, and one that scientists have come a long way in understanding." said Charlie Rose. "Though a number of factors, such as anti-smoking campaigns, improved diet and exercise recommendations, and the development of effective drugs, is improving disease outlook, much remains to be done."

Charlie's distinguished guests will include: Steven Nissen, MD, MACC, Chair of the Department of Cardiovascular Medicine at the Cleveland Clinic Foundation; Lori Mosca, MD, MPH, PhD., Director of Preventive Cardiology at New York Presbyterian Hospital/Columbia; Harlan Krumholz, MD, Harold H. Hines Junior Professor of Medicine and Epidemiology, and Public Health at Yale University; and Lance Becker, MD, Director of the Center for Resuscitation Science and Professor of Emergency Medicine at the University of Pennsylvania.

Heart disease is a broad term which includes several more specific heart conditions. The most common heart condition in the United States is coronary heart disease, which leads to heart attack or other serious conditions. Other conditions which are included in heart disease are Aortic Aneurysms, Arrhythmias, Cardiomyopathy, and Peripheral Arterial Disease.

"At Pfizer, we are looking beyond our groundbreaking work in cholesterol control and are making advances in understanding those other risk factors that can lead to heart disease," said Dr. Steven Ryder, therapeutic leader for cardiovascular medicine at Pfizer. "Our current and future portfolio of medicines focuses on the control of risk factors inherent in smoking, diet, physical activity, and Type 2 diabetes. We are committed to playing a more significant role in providing solutions for patients that lead to better health and disease prevention."

Because of advances in medicine and technology, people with heart disease are living longer, more productive lives than ever before. However, global trends like obesity, smoking, rising diabetes, high blood pressure, and poor lifestyle undermine many of the improvements that have been made toward the prevention of heart disease. According to the World Health Organization, physical inactivity and unhealthy diet are main risk factors which increase individual risks to cardiovascular diseases.

"While genetics has an effect on heart disease, big increases have been associated with lifestyle decisions, something that we can control, but by and large choose not to," noted Dr. Nurse. "As research moves forward, we will learn more about the disease by understanding people's genetic predispositions towards cardiovascular disease. Ultimately, it's the interaction between genetics and person's environment and lifestyle that's the key issue."

Pfizer's support for the Charlie Rose Science Series and its exploration of the advances being made in scientific research, their contribution to our understanding of the world around us, and how these breakthroughs may be applied to improving human health is part of Pfizer's commitment to expanding scientific understanding.

Past episodes of the Charlie Rose Science Series have explored research that has led to a better understanding of the human brain; the discovery and mapping of human DNA; new insights into longevity and the body's aging mechanisms; an in-depth look at cancer, the latest advances in stem cell research; the problem of obesity in the American population especially among children and teenagers; and the continually growing problem of HIV/AIDS worldwide.

For more information about the Charlie Rose Science Series or to watch clips from past episodes, please visit http://www.charlierose.com .


'/>"/>
SOURCE Charlie Rose Show
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Science of swooning
2. Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru
3. The Science of Solar Eclipse
4. The Unpredictable Face Of Science
5. Science backs the importance of vegetables in diet
6. Weizmann Institute of Science says Immune Cells Could Help Maintain Brain Function
7. US Academy honors 15 for major contributions to science
8. East And West Meet Under The Aegis of NY Academy Of Sciences
9. Getting Basic Science to Work For Medicine
10. Sleep Science awakens from deep slumber!
11. Arab World Wakes Up To the Call of Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... ... After a year and a half of planning the Multiple Pathways of Recovery Conference ... of Recovery Conference was held May 2 -4, 2016 at the Mystic Marriott Hotel ... to explore the many pathways individuals use to get into and sustain their recovery. ...
(Date:5/27/2016)... ... ... W.S. Badger Co. Inc ., the maker of certified organic and ... of the best small businesses for new dads by Fatherly, the digital lifestyle guide ... progressive benefits to new parents on the organization’s 2016 Best Places to Work ...
(Date:5/27/2016)... ... May 27, 2016 , ... In ... the many who are unaware of the plight of aphasia. In collaboration with ... the “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively ...
(Date:5/27/2016)... ... May 27, 2016 , ... With a team of ... food industries. Aside from its GMP accreditation, Validation Center is also a registered ... products, services and staff. , Validation Center is ISO17025 accredited and only offers ...
(Date:5/26/2016)... St. Louis, Missouri (PRWEB) , ... May 26, ... ... optimal cost, quality and clinical outcomes, hosted members and suppliers for its inaugural ... with a focus on their mission of elevating the operational health of America’s ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 ... biopharma company focused on the highly lucrative global ... substantial pipeline of potential first-in-class or best-in-class tyrosine ... in development with strategic partners. HCM,s profitable Chinese ... domestic market. We expect progress of the mid-to-late-stage ...
(Date:5/26/2016)... , May 26, 2016 According to ... Waste Management Market - U.S. Industry Analysis, Size, Share, Growth, ... market in the U.S. was valued at US$ 5.89 Bn ... of 3.4% from 2015 to 2023 to reach US$ 7.99 ... of current and emerging needle free drug delivery devices and ...
(Date:5/26/2016)... May 26, 2016 Since its ... into an essential life science tool for conducting genetic ... BCC Research reveals in its new report that the ... phase, one powered by a range of new applications ...      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
Breaking Medicine Technology: